Adrenal&Incidentaloma:& Clinical&Pathological&Correla9on& Paul Gustafson Dr. Edward Jones, Dr. Charles Zwirewich, Dr. Marshal Dahl.
|
|
|
- Brian Burns
- 7 years ago
- Views:
Transcription
1 Adrenal&Incidentaloma:& Clinical&Pathological&Correla9on& Paul Gustafson Dr. Edward Jones, Dr. Charles Zwirewich, Dr. Marshal Dahl Outline& Review&Incidence,&Epidemiology& Case&presenta9on& Dr.$Charles$Zwirewich,$Radiology& &&&&&&&&&%Review&of&Imaging$ Dr.$Marshall$Dahl,$Endocrinology& &&&&&&&&&%Biochemical&Evalua9on& Dr.$Edward$Jones,$Pathology& &&&&&&&&&%Review&of&Pathology& Surgical&Management& Follow%Up& 1&
2 Adrenal&Incidentaloma&%&Defini9on& Adrenal&&lesions&&larger&&than&&1cm&&found& serendipitously&&&during&&imaging&&studies& performed&&for&&reasons&&other&&than& evalua9on&&of&&adrenal&&disease. & Young Endorinol Metab Clin North Am 2000; 29: Incidence&and&Epidemiology& Frequency&of&adrenal&adenoma&6%&on&autopsy&&&&& Incidentaloma&in&up&to&5%&pts&undergoing& abdominal&or&thoracic&ct&&& Probability&increases&with&age&(0.2%&age&&20%29&yrs,& 7%&age&>&70yrs)& Detec9on&increasing&with&higher&&resolu9on&imaging& & & & Young.&&N""Eng""J""Med.&&2007;&&356:601& Davenport&Endocrine&2011;40:&80%83& 2&
3 Incidence&and&Epidemiology& Non%func9oning&benign&lesion&82.5%&& &&&&&%61%&adenoma& &&&&&%10%&myolipoma& &&&&&%&6%&adrenal&cyst& &&&&&%&5.5%&ganlioneuroma& Cor9sol%secre9ng&adenoma&5.3%& Pheochromocytoma&5.1%& Adrenocor9cal&carcinoma&4.7%& Metastases&2.5%& Aldosteronoma&1%& Turner.&&Curr""Opin""Oncol.&&2009;&&21:34& Bi^ner.&Surg&onc&2012;&106:&557%564& Incidence&and&Epidemiology& Offer&tes9ng&to:& %Rule&out&func9onal&secretory&lesion& %Rule&out&malignancy&(primary&or&metastases)& 3&
4 Case&%&HPI& ID:&69&year&old&male& %CT&chest&ordered&to&inves9gate&dyspnea,& possible&inters99al&lung&disease& %incidentally&discovered&lea&adrenal&mass& %no&other&new&signs&or&symptoms&sugges9ve&of& func9onal&adenoma,&acc,&metastases& History&and&Physical& 4&
5 Case&%&PMHx& PMHx:& OSA&%&prescribed&CPAP,¬&compliant& COPD,&?ILD&%&requiring&home&O2,&2.5&L/min&at& night& HTN&%&20&yrs,&controlled&with&HCTZ& Obesity&%&BMI&30& DM2& &insulin%dependent& Dyslipidemia& Depression& PSHx:& &open&cholecystectomy,&appendectomy& Case&%&Meds/Allergies& Meds:& Mehormin&500&mg&BID& Glyburide&5&mg&BID& Insulin&NPH&36/0/0/0& Lipitor& HCTZ& Prozac& Allergies:& NKDA& & 5&
6 Case&%&Imaging& CT&chest&%&4.7&cm&heterogeneous&adrenal&mass& suspicious&for&primary&malignancy&or&mets& CT&Adrenal&protocol& &5.4&cm&mass&with&57%& washout&at&60&sec,&could&represent&primary& malignancy&or&mets,& amenable&to& percutaneous&biopsy & Limited&role& Biopsy&indica9ons:& %suspected&infec9on& %supected&adrenal&mets&& Biopsy& Oaen&non%diagnos9c,&may¬&differen9ate& benign&from&malignant& Risk&of&hypertensive&crisis&with&pheo& 6&
7 Percutaneous&Biopsy&& Case&%&Biopsy& Referral to VGH given patients co-morbidities Dr.&Zwirewich&%&Radiology& 7&
8 CGH&&12/2011&CT&chest&+C& Lt&Adrenal&mass&>&4.8cm&117HU& CGH&&1/2012&Adrenal&Washout&CT&& Lt&&Adrenal&mass&6.5cm&& NC&39.4HU & &1&min&100HU & &15&min&62.6HU& Absolute&Percentage&Washout&(APW)&=&62%& 8&
9 CGH&&2012&13mm&Rt&Renal&Mass& NC&30.2HU & & &60&sec&80.9&HU && >20HU&enhancement&strongly&suggests&malignancy& CGH&&2/2012&CT&Guided&biopsy& Lt&&Adrenal&mass&6.5cm&& 9&
10 VGH&&5/2012& 123 I%MIBG&scan& Non&MIBG&avid&6cm&mass.&1cm&focus&uptake&likely&normal&& Incidentally Detected Adrenal Mass (IDAM) Mass &1cm discovered incidentally on cross-sectional imaging performed for another reason 3-7% of adult population Pathology: 71.2% non-functioning adenoma Frequently investigated to exclude potentially serious (malignant) lesion: metastasis, pheo, ACC, lymphoma IDAMs <2cm with no Hx of cancer are rarely malignant IDAMs in cancer patients are frequently mets (45-73%) 10&
11 Imaging Parameters Size CT Internal architecture Pre contrast attenuation Post contrast enhancement and washout MRI Chemical shift imaging (CSI) T2 SI Gd Enhancement 11&
12 Fat attenuation < -30HU 12&
13 Adrenal&Myelolipoma& CT of Lipid Rich Adrenal Adenomas Non-contrast attenuation <2HU Sensitivity 47% Specificity 100% Non-contrast attenuation <10HU (ACR) Sensitivity 71% Specificity 98% Johnson&PT&&Radiographics&2009&29:1319& & 13&
14 Lipid&Rich&Adenoma& NC: 8HU NC: -3HU MRI of Adrenal Adenoma Lipid rich Opposed phase imaging In phase (TE=4.2ms) Relatively hyperintense Out of phase (TE=2.1,6.6) Signal drop out (microscopic fat) Sensitivity % Specificity % 14&
15 Characterization of IDAMs with Adrenal washout CT Technique: NC, 1 and 15 minutes post IV contrast Absolute percentage washout (APW) used at VGH APW 60% confirms adenoma* APW sensitivity 98% and specificity 92% *Caveats: APW only applicable to IDAMs 4cm Analysis most valuable for homogeneous masses Consider pheo if IDAM >100HU enhancement at 1 minute regardless of APW Berland&LL&JACR&2010&7:754& Horton&KM&AJR&2010&194:660& 15&
16 Adrenal&washout&CT& NC: 19H 1 min: 76H 15 min: 32H Lipid poor adrenal adenoma: APW 77% 16&
17 CGH&&1/2012&Adrenal&Washout&CT&& Lt&&Adrenal&mass&6.5cm&& NC&39.4HU & &1&min&100HU & &15&min&62.6HU& Absolute&Percentage&Washout&(APW)&=&62%& Adrenal&malignancies& Adrenal cortical carcinoma Adrenal metastases from lung cancer 17&
18 Sag&T2& Pheochromocytoma Ax&T2& Ax&T1& Ax&T1+gad& Non-functioning Pheochromocytoma Ax$T2$fat$sat$ Cor$T2$ Ax$T1$with$gad$ 18&
19 Key points: IDAMs are common Size is not a reliable indicator of malignancy No cancer Hx: most IDAMs <2-3cm are benign Cancer Hx: 45-73% of masses are metastases Bilaterality favors mets, lymphoma, hemorrhage Key points (2): NC CT attenuation <10HU: lipid rich adenoma < -30HU: myelolipoma Signal loss on CSI MR: lipid rich adenoma Peak CT enhancement < 100HU and APW >60% suggests lipid-poor adenoma Peak CT enhancement >100HU always consider pheo Hi intensity T2 MR and strong enhancement with Gd: always consider pheo 19&
20 Extramedullary&Hematopoeisis& Adrenal mass Gallstones, splenomegaly T1: Iron overload, Paraspinal EMH Case& &Hormonal&Evalua9on& 20&
21 Marshall Dahl MD PhD FRCPC cert Endo Clinical Professor, Endocrinology, UBC Alternate&Title:& What&could&possibly&go&wrong...?& 21&
22 Defini9on& & Adrenal&incidentaloma:& &! Mass&lesion&>&1cm&discovered&by&radiologic& examina9on&in&the&absence&of&symptoms&or& clinical&findings&sugges9ve&of&adrenal& disease& Thompson&&&Young.&Curr&Opin&Oncol&Jan&2003& Epidemiology& Prevalence&of&adrenal&masses&varies&according&to& criteria&and&circumstances& Autopsy&series:& 1.4%2.9%&>&1cm& 8.7%&>&2&mm& CT&series:& 0.6%1.9%&in&general&popula9on& 4.0%&in&pa9ents&with&lung&cancer& & & Mansmann&et&al.&Endo&Rev&2004&& & 22&
23 Differen9al&Diagnosis& 2% & && 2% 5% 8% 8% 11% 12% 52% Adenoma 52% Carcinoma 12% Pheochromocytoma 11% Myelolipoma 8% Subclinical Cushings 5% Metastases 2% Aldosterone PA 2% Other 8% Mantero&et&al.&J&Clin&Endocrinol&Metab&2000& Two&Ques9ons& Is&it&malignant?& Size&and&imaging&phenotype& & Is&it&func9oning?& History&and&Physical& Hormonal&assessment& 23&
24 Adrenocor9cal&Carcinoma& 88% Other Carcinoma 12% Prevalence&of&carcinoma&based&on&size:& Masses&<&4&cm&:&2%& Masses&4%6&cm:&6%& Masses&>&6&cm:&25%& Vierhapper&et&al.&Clin&Endocrinol&Diabetes&2003& Cushing s&syndrome& Spectrum&of&symptoms&from&asymptoma9c&to& classic&phenotype& Hypertension,&osteoporosis,&diabetes,& dyslipidemia& Overnight&1&mg&dexamethasone&suppression& test.&&am&cor9sol&should&be&below&130& Confirmatory&tes9ng&with&2&day&high&dose& tes9ng& 24&
25 Primary&hyperaldosteronism& Hypertension& Hypokalemia&oaen¬&present& Upright&morning&aldosterone&renin&ra9o&off& intefering&meds:&spironlactone,&acei& Saline&suppression&tes9ng&+/%&adrenal&vein& sampling& Pheochromocytoma& Spectrum&from&asymptoma9c&to&paroxysmal& hyperadrenergic& Hypertension,&orthosta9c&hypotension,&pallor,& re9nopathy& 24&hour&metanephrines&best&screen.& False&posi9ves&with&drugs:&tricyclics,&clozapine,& sympathomime9cs,&buspirone&and&lesser& effect&with&beta&and&alpha&blockers& 25&
26 Adrenocor9cal&carcinoma& Mass&effect& Possible&Cushing s&syndrome&or& Androgen&secre9on&(viriliza9on&in&women)& Estrogens&secre9on&(gynecomas9a)& Hyperaldosteronism& Young W. N Engl J Med 2007;356: &
27 (Surgery&2009;146:1158%66.)& Mayo&Biopsy&Experience& 20&consecu9ve&pa9ents& Retrospec9ve&record&review& 14&pheos&and&6¶gangliomas&biopsied&prior& to&referral& No&pre%biopsy&biochemical&tes9ng&in&90%,&and& nega9ve&in&remainder& 70%&developed&a&biopsy%related&complica9on& 27&
28 28&
29 Summary& Adrenal&incidentalomas&common& Imaging&phenotype&for&malignancy&poten9al& 24&hour&metanephrines& Overnight&1&mg&dex&suppression&test& +/%&morning&aldosterone%renin&ra9o& 29&
30 Case&%&Management& Anesthesia&and&Endocrinology&consults& Normal&Echocardiogram& Mixed&alpha/beta&blockade&with&labetolol& 100mg&BID&pre%opera9vely& Intended&Lea&MIS&Adrenalectomy& Appeared&Invasive&into&upper&pole& MIS&Nephrectomy&and&Adrenalectomy&en&bloc& Well&at&last&f/u,&5&months&post%op& Pathology& &Dr.&Jones& 30&
31 Pathology& 31&
32 32&
33 33&
34 34&
35 35&
36 Thank&you& 36&
37 Surgical&Management& Surgical&&approaches:& &Open&&& &Laparoscopic& &&&&&%transperitoneal& &&&&&%retroperitoneal& &Robo9c& Surgical&Management& Laparoscopic&adrenalectomy&standard&of&care& Equivalent&outcomes&with&open& Less&morbidity,&pain,&shorter&LOS& Size&threshold&con9nuously&challenged&(10,& 15cm?)& Open&for:& &&&&&%larger&&or&&invasive&&tumors&&& &&&&&%vein&&involvement& &&&&&%emergent&&open&&surgical&&conversion& & 37&
38 Follow%Up& 1&mg&DXT,&urinary&metanephrines&and& catecholamines,&k&and&renin/aldo&those&with& HTN&annually&for&4&years& Monitor&lesions&<&4&cm&with&CT&at&6,&12&and&24& months& Pheo&%&Follow%Up& Long%term&follow%up&& &&&&&%10%year&recurrence&rates&up&to&16%& Biochemical&tes9ng&6&months&post%op,&then& annually& Post%op&imaging&to&document&resec9on& 38&
Measure #405: Appropriate Follow-up Imaging for Incidental Abdominal Lesions National Quality Strategy Domain: Effective Clinical Care
Measure #405: Appropriate Follow-up Imaging for Incidental Abdominal Lesions National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION:
CT and MRI features of the Pathologic Subtypes of Papillary Renal Cell Carcinoma. Melissa Price, MD Aoife Kilcoyne, MD Mukesh G.
CT and MRI features of the Pathologic Subtypes of Papillary Renal Cell Carcinoma Melissa Price, MD Aoife Kilcoyne, MD Mukesh G. Harisinghani, MD Disclosures Neither I nor my immediate family members have
Kidney Cancer OVERVIEW
Kidney Cancer OVERVIEW Kidney cancer is the third most common genitourinary cancer in adults. There are approximately 54,000 new cancer cases each year in the United States, and the incidence of kidney
Managing Incidental Findings on Abdominal CT: White Paper of the ACR Incidental Findings Committee
Managing Incidental Findings on Abdominal CT: White Paper of the ACR Incidental Findings Committee Lincoln L. Berland, MD a, Stuart G. Silverman, MD b, Richard M. Gore, MD c, William W. Mayo-Smith, MD
Laparoscopic Adrenal Gland Removal (Adrenalectomy) Patient Information from SAGES
Laparoscopic Adrenal Gland Removal (Adrenalectomy) Patient Information from SAGES What are the Adrenal Glands? The adrenal glands are two small organs, one located above each kidney. They are triangular
Optimizing imaging in adrenal pathology
Genitourinary/Update in Radiology Optimizing imaging in adrenal pathology M.C. Binda a, *, C. Afione b, J. Miklaszewski a, E. Pardes a,c, E. Enríquez a y R. López a a. Division of Imaging Diagnosis, Hospital
Characterization of small renal lesions: Problem solving with MRI Gary Israel, MD
Characterization of small renal lesions: Problem solving with MRI Gary Israel, MD With the widespread use of cross-sectional imaging, many renal masses are incidentally found. These need to be accurately
Disorders of the Adrenal Glands
Disorders of the Adrenal Glands Presley Regional Trauma Center Department of Surgery University of Tennessee Health Science Center Memphis, Tennessee Physiology Cortex Steroid hormones cortisol, aldosterone
LOYOLA UNIVERSITY MEDICAL CENTER RESIDENCY PROGRAM IN GENERAL SURGERY CLINICAL ROTATION DESCRIPTION
LOYOLA UNIVERSITY MEDICAL CENTER RESIDENCY PROGRAM IN GENERAL SURGERY CLINICAL ROTATION DESCRIPTION Loyola University Medical Center Department of Surgery Endocrine Surgery RESIDENT COMPLEMENT: ROTATION
WHAT S WRONG WITH MY GALL BLADDER? GALL BLADDER POLYPS
WHAT S WRONG WITH MY GALL BLADDER? GALL BLADDER POLYPS This is a patient information booklet providing specific practical information about gall bladder polyps in brief. Its aim is to provide the patient
False positive PET in lymphoma
False positive PET in lymphoma Thomas Krause Introduction and conclusion 2 3 Introduction 4 FDG-PET in staging of lymphoma 34 studies with 2227 Patients CT FDG-PET Sensitivity 63 % 89 % (58%-100%) (63%-100%)
Radiologic Diagnosis of Spinal Metastases
September 2002 Radiologic Diagnosis of Spinal Metastases Natalie J. M. Dailey, Harvard Medical Student Year III Our Patient s Presenting Story 70 year old male Presents to the hospital for laparascopic
Objectives. Mylene T. Truong, MD. Malignant Pleural Mesothelioma Background
Imaging of Pleural Tumors Mylene T. Truong, MD Imaging of Pleural Tumours Mylene T. Truong, M. D. University of Texas M.D. Anderson Cancer Center, Houston, TX Objectives To review tumors involving the
Ultrasonography of the Adrenal Glands CVM 6105 Kari L. Anderson, DVM, Diplomate ACVR Associate Clinical Professor of Veterinary Radiology
1: US of adrenal glands, KLA Ultrasonography of the Adrenal Glands CVM 6105 Kari L. Anderson, DVM, Diplomate ACVR Associate Clinical Professor of Veterinary Radiology Ultrasound has quickly become an important
Quick Tips for Use of Audience Response Systems (ARS)
Quick Tips for Use of Audience Response Systems (ARS) Office of Continuing Education and Professional Development Faculty of Medicine University of Toronto 500 University Avenue, Suite 650 Toronto, Ontario
GENERAL CODING. When you review old cases that were coded to unknown, make corrections based on guidelines in effect at the time of diagnosis.
GENERAL CODING When you review old cases that were coded to unknown, make corrections based on guidelines in effect at the time of diagnosis. Exception: You must review and revise EOD coding for prostate
D. FREQUENTLY ASKED QUESTIONS
ACR BI-RADS ATLAS D. FREQUENTLY ASKED QUESTIONS 1. Under MQSA, is it necessary to include a numeric assessment code (i.e., 0, 1, 2, 3, 4, 5, or 6) in addition to the assessment category in all mammography
SUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD
SUNY DOWNSTATE MEDICAL CENTER SURGERY GRAND ROUNDS February 28, 2013 VERENA LIU, MD ROSEANNA LEE, MD Case Presentation 35 year old male referred from PMD with an asymptomatic palpable right neck mass PMH/PSH:
GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER
GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER BY Ali Shamseddine, MD (Coordinator); as04@aub.edu.lb Fady Geara, MD Bassem Shabb, MD Ghassan Jamaleddine, MD CLINICAL PRACTICE GUIDELINES FOR THE TREATMENT
Challenges in gastric, appendiceal and rectal NETs Leuven, 29.11.2014
Challenges in gastric, appendiceal and rectal NETs Leuven, 29.11.2014 Prof. Dr. Chris Verslype, Leuven Prof. Dr. Aurel Perren, Bern Menue Challenges: 1. Gastric NET 2. Appendiceal NET 3. Rectal NET SEER,
CONTEMPORARY MANAGEMENT OF RENAL ANGIOMYOLIPOMA
CONTEMPORARY MANAGEMENT OF RENAL ANGIOMYOLIPOMA Stephen A. Boorjian, MD Professor of Urology Vice Chair of Research Director, Urologic Oncology Fellowship Department of Urology Mayo Clinic, Rochester,
An Open Source Web-based Application for Radiology Decision Support
An Open Source Web-based Application for Radiology Decision Support William W Boonn MD and Curtis P Langlotz MD PhD Department of Radiology Hospital of the University of Pennsylvania Philadelphia, PA Disclosures
PET/CT in Lung Cancer
PET/CT in Lung Cancer Rodolfo Núñez Miller, M.D. Nuclear Medicine and Diagnostic Imaging Section Division of Human Health International Atomic Energy Agency Vienna, Austria GLOBOCAN 2012 #1 #3 FDG-PET/CT
Metastatic Renal Cell Carcinoma: Staging and Prognosis of Three Separate Cases.
Metastatic Renal Cell Carcinoma: Staging and Prognosis of Three Separate Cases. Abstract This paper describes the staging, imaging, treatment, and prognosis of renal cell carcinoma. Three case studies
THYROID CANCER. I. Introduction
THYROID CANCER I. Introduction There are over 11,000 new cases of thyroid cancer each year in the US. Females are more likely to have thyroid cancer than men by a ratio of 3:1, and it is more common in
Radiology Workload and Follow-up Considerations
Radiology Workload and Follow-up Considerations William C. Black, MD Department of Radiology Norris Cotton Cancer Center Dartmouth-Hitchcock Medical Center william.c.black@hitchcock.org No financial disclosures
Nicole Kounalakis, MD
Breast Disease: Diagnosis and Management Nicole Kounalakis, MD Assistant Professor of Surgery Goal of Breast Evaluation The goal of breast evaluation is to classify findings as: normal physiologic variations
Surveillance for Hepatocellular Carcinoma
Surveillance for Hepatocellular Carcinoma Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco Recorded on April
Cancer of the Cervix
Cancer of the Cervix WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500 A woman's cervix (the opening of the uterus) is lined with cells. Cancer of the cervix occurs when those cells change,
Case Number: RT2009-124(M) Potential Audiences: Intent Doctor, Oncology Special Nurse, Resident Doctor
Renal Cell Carcinoma of the Left Kidney Post Radical Surgery with pt4 Classification with Multiple Lung and Single Brain Metastases: the Role and Treatment Consideration of Radiotherapy Case Number: RT2009-124(M)
Renal Cell Carcinoma. Background 1. General information. Pathophysiology 1. Pathology of disease. Diagnostics 1. History
Renal Cell Carcinoma Background 1. General information o Accounts for 2-3 % of all malignancies o 5 variants 75-85% clear cell tumors 12-14% chromophilic 4-6% chromophobic 2-4% oncocytic 1% collecting
Benign Ovarian Masses
Benign Ovarian Masses Anthony Hanbidge Learning Objectives Describe technique for assessment of ovarian masses Explain importance of transvaginal scan List the common benign masses Specify distinguishing
Catholic Medical Center & Androscoggin Valley Hospital. Surgical Weight Loss Options For a Healthier Tomorrow
Catholic Medical Center & Androscoggin Valley Hospital Surgical Weight Loss Options For a Healthier Tomorrow Presentation Overview Obesity Health Related Risks Who Qualifies for Weight Loss Surgery? Gastric-bypass
Cystic Neoplasms of the Pancreas: A multidisciplinary approach to the prevention and early detection of invasive pancreatic cancer.
This lecture is drawn from the continuing medical education program Finding Hope: Prevention, Early Detection and Treatment of Pancreatic Cancer, Nov, 2011. Robert P. Jury, MD Cystic Neoplasms of the Pancreas:
Case Number: RT2009-114(M) Potential Audiences: Intent Doctor, Oncology Special Nurse, Resident Doctor
Extensive-Stage Small Cell Lung Cancer Post Full-Course Chemotherapy with Residual Locoregional Cancer Disease: the Role and Treatment Consideration of Radiotherapy Case Number: RT2009-114(M) Potential
Contrast-Enhanced Ultrasound (CEUS)
Contrast-Enhanced Ultrasound (CEUS) Odd Helge Gilja, MD, PhD Professor Department of Medicine Haukeland University Hospital Bergen, Norway The Micro-Bubble Contrast Agents - World View IEEE Transactions
Renal Cysts What should I do now?
Renal Cysts What should I do now? Dr Edmund Chiong Asst. Professor & Consultant Department of Urology National University Hospital What are renal cysts? Fluid-filled structures in the kidney that are not
Screening for Cancer in Light of New Guidelines and Controversies. Christopher Celio, MD St. Jude Heritage Medical Group
Screening for Cancer in Light of New Guidelines and Controversies Christopher Celio, MD St. Jude Heritage Medical Group Screening Tests The 2 major objectives of a good screening program are: (1) detection
Disclosures. Definitions. CDC Website
Disclosures Deborah Grady, MD, MPH Professor of Medicine Deputy Editor, JAMA Internal Medicine Co-Director, Center for Healthcare Value Co-Director, Clinical and Translational Science Institute Salary
Malignant Pleural Diseases Advances Clinicians Should Know F Gleeson
Malignant Pleural Diseases Advances Clinicians Should Know F Gleeson The following relevant disclosures, conflicts of interest and/ or financial relationships exist related to this presentation: Consultant
Intraoperative Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Volodymyr Labinskyy MD
Intraoperative Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Volodymyr Labinskyy MD KCHC 8/29/13 52 y.o. F presented with severe pain in the right back and right flank, sharp, 8 out of 10, for 7 days.
Bridging Techniques. What s between EMR and Traditional Surgery? Elisabeth C. McLemore, MD, FACS, FASCRS
Bridging Techniques What s between EMR and Traditional Surgery? Elisabeth C. McLemore, MD, FACS, FASCRS Associate Professor of Surgery Assistant Program Director, General Surgery Residency Disclosures
Update on thyroid cancer surveillance and management of recurrent disease. Minimally invasive thyroid surgery
Update on thyroid cancer surveillance and management of recurrent disease Minimally invasive thyroid surgery July 2006 Michael W. Yeh, MD Program Director, Endocrine Surgery Assistant Professor, David
Oncology. Objectives. Cancer Nomenclature. Cancer is a disease of the cell Cancer develops when certain cells begin to grow out of control
Oncology Objectives Describe the etiology and pathophysiological mechanisms of cancer Discuss medical and family history findings relevant to cancer Identify general signs and symptoms associated with
Metastatic Cervical Cancer s/p Radiation Therapy, Radical Hysterectomy and Attempted Modified Internal Hemipelvectomy
Metastatic Cervical Cancer s/p Radiation Therapy, Radical Hysterectomy and Attempted Modified Internal Hemipelvectomy Sarah Hutto,, MSIV Marc Underhill, M.D. January 27, 2009 Past History 45 yo female
Case Report: Whole-body Oncologic Imaging with syngo TimCT
Case Report: Whole-body Oncologic Imaging with syngo TimCT Eric Hatfield, M.D. 1 ; Agus Priatna, Ph.D. 2 ; John Kotyk, Ph.D. 1 ; Benjamin Tan, M.D. 1 ; Alto Stemmer 3 ; Stephan Kannengiesser, Ph.D. 3 ;
Translocation Renal Cell Carcinomas
Translocation Renal Cell Carcinomas Cora N. Sternberg, MD, FACP Chair, Department of Medical Oncology San Camillo and Forlanini Hospitals Rome, Italy Kidney cancer is not a single disease Clear cell (75%)
WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1557/14
WORKPLACE SAFETY AND INSURANCE APPEALS TRIBUNAL DECISION NO. 1557/14 BEFORE: M. Crystal: Vice-Chair HEARING: August 20, 2014 at Toronto Written DATE OF DECISION: December 4, 2014 NEUTRAL CITATION: 2014
Listen to your heart: Good Cardiovascular Health for Life
Listen to your heart: Good Cardiovascular Health for Life Luis R. Castellanos MD, MPH Assistant Clinical Professor of Medicine University of California San Diego School of Medicine Sulpizio Family Cardiovascular
Issues Concerning Development of Products for Treatment of Non-Metastatic Castration- Resistant Prostate Cancer (NM-CRPC)
Issues Concerning Development of Products for Treatment of Non-Metastatic Castration- Resistant Prostate Cancer (NM-CRPC) FDA Presentation ODAC Meeting September 14, 2011 1 Review Team Paul G. Kluetz,
Surgical Management of Papillary Microcarcinoma 趙 子 傑 長 庚 紀 念 醫 院 林 口 總 院 一 般 外 科
Surgical Management of Papillary Microcarcinoma 趙 子 傑 長 庚 紀 念 醫 院 林 口 總 院 一 般 外 科 Papillary microcarcinoma of thyroid Definition latent aberrant thyroid occult thyroid carcinoma latent papillary carcinoma)
Adjuvant Therapy Non Small Cell Lung Cancer. Sunil Nagpal MD Director, Thoracic Oncology Jan 30, 2015
Adjuvant Therapy Non Small Cell Lung Cancer Sunil Nagpal MD Director, Thoracic Oncology Jan 30, 2015 No Disclosures Number of studies Studies Per Month 12 10 8 6 4 2 0 1 2 3 4 5 6 7 8 9 10 11 12 1 2 3
Sustaining a High-Quality Breast MRI Practice
Sustaining a High-Quality Breast MRI Practice Christoph Lee, MD, MSHS Associate Professor of Radiology Adjunct Associate Professor, Health Services University of Washington September 11, 2015 Overview
ADRENAL CORTICAL CANCER
ADRENAL CORTICAL CANCER What is cancer? Cancer develops when cells in a part of the body begin to grow out of control. Although there are many kinds of cancer, they all start because of out-of-control
In The Abstract A quarterly newsletter from the
In The Abstract A quarterly newsletter from the Kentucky Cancer Registry Large Hospital Edition July, 2000 KCR FALL WORKSHOP Sept. 14-16, 2000 Enclosed with this newsletter is a packet of information containing
MRI of Bone Marrow Radiologic-Pathologic Correlation
MRI of Bone Marrow Radiologic-Pathologic Correlation Marilyn J. Siegel, M.D. Mallinckrodt Institute of Radiology Washington University School of Medicine St. Louis, MO and Visiting Scientist, AFIP, Washington,
How common is bowel cancer?
information Primary Care Society for Gastroenterology Bowel Cancer (1 of 6) How common is bowel cancer? Each year 35,000 people in Britain are diagnosed with cancer of the bowel, that is to say cancer
Cardiac Masses and Tumors
Cardiac Masses and Tumors Question: What is the diagnosis? A. Aortic valve myxoma B. Papillary fibroelastoma C. Vegetation from Infective endocarditis D. Thrombus in transit E. None of the above Answer:
Four Important Facts about Kidney Cancer
Volume Article.13-11 Publish Date: 24th June 2013 Author(s): MPUH - CRS Team Four Important Facts about Kidney Cancer ARTICLE hhh Muljibhai Patel Urological Hospital (MPUH) Centre For Robotic Surgery (CRS)
Guidelines for Management of Renal Cancer
Guidelines for Management of Renal Cancer Date Approved by Network Governance July 2012 Date for Review July 2015 Changes Between Versions 2 and 3 Section 5 updated bullets 5.3 and 5.4 Section 6 updated
Ovarian cysts Diagnosis and Management
Ovarian cysts Diagnosis and Management Mr P K Athanasias MRCOG Consultant Gynaecologist St Anthony s Hospital pathanasias@gmail.com Introduction ovary is an ovum-producing reproductive organ located in
Adrenal Cancer Overview
Adrenal Cancer Overview The information that follows is an overview of this type of cancer. For more detailed information, call 1-800-227-2345. Or visit our Web site at www.cancer.org. What is cancer?
The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery
The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery Michael E. Farkouh, MD, MSc Peter Munk Chair in Multinational Clinical Trials Director, Heart and Stroke
Low-dose CT Imaging. Edgar Fearnow, M.D. Section Chief, Computed Tomography, Lancaster General Hospital
Lung Cancer Screening with Low-dose CT Imaging Edgar Fearnow, M.D. Section Chief, Computed Tomography, Lancaster General Hospital Despite recent declines in the incidence of lung cancer related to the
PROTOCOL OF THE RITA DATA QUALITY STUDY
PROTOCOL OF THE RITA DATA QUALITY STUDY INTRODUCTION The RITA project is aimed at estimating the burden of rare malignant tumours in Italy using the population based cancer registries (CRs) data. One of
In Practice Whole Body MR for Visualizing Metastatic Prostate Cancer
In Practice Whole Body MR for Visualizing Metastatic Prostate Cancer Prostate cancer is the second most common cancer in men worldwide, accounting for 15% of all new cancer cases. 1 Great strides have
Renal Cell Carcinoma The New Frontier (To boldly go... ) Sean A. Pierre, MD, RCPSC (Urology)
The New Frontier (To boldly go... ) Sean A. Pierre, MD, RCPSC (Urology) QUEENSWAY CARLETON HOSPITAL DIVISION OF UROLOGY NEPEAN, ON, CANADA Disclosures None Objectives Advances in the field of Renal Cell
Breast Imaging Made Brief and Simple. Jane Clayton MD Associate Professor Department of Radiology LSUHSC New Orleans, LA
Breast Imaging Made Brief and Simple Jane Clayton MD Associate Professor Department of Radiology LSUHSC New Orleans, LA What women are referred for breast imaging? Two groups of women are referred for
Benign Liver Tumors. Cameron Schlegel PGY-1 3/6/2013
Benign Liver Tumors Cameron Schlegel PGY-1 3/6/2013 Outline Benign Liver Tumors are, in general. Asymptomatic Diagnosed: imaging Treatment: Do no harm Unless Malignant potential Causing symptoms Differential
Ovarian Cancer Genetic Testing: Why, When, How?
Ovarian Cancer Genetic Testing: Why, When, How? Jeffrey Dungan, MD Associate Professor Division of Clinical Genetics Department of Obstetrics & Gynecology Northwestern University Feinberg School of Medicine
The Role of Genetic Testing in the Evaluation of Thyroid Nodules. Thyroid Cancer and FNA. Thyroid Cancer. Pure Follicular Cancers.
Where does Molecular Analysis of FNA Specimens fit into the evaluation of thyroid nodules? The Role of Genetic Testing in the Evaluation of Thyroid Nodules Ultrasound TSH Risk factors Jill E. Langer, MD
Table of Contents. User Instructions...Page 2. Group Administrator (Chief/Department Chair or Point of Contact (POC).Page 3
Table of Contents User Instructions......Page 2 Group Administrator (Chief/Department Chair or Point of Contact (POC).Page 3 Report Index and Sample Reports.Page 16 Example of Scoring..Page 19 1 RADPEER
The Lewin Group undertook the following steps to identify the guidelines relevant to the 11 targeted procedures:
Guidelines The following is a list of proposed medical specialty guidelines that have been found for the 11 targeted procedures to be included in the Medicare Imaging Demonstration. The list includes only
AACE Advances in Medical and Surgical Management of Thyroid Cancer, 2015. Tampa, Florida.
AACE Advances in Medical and Surgical Management of Thyroid Cancer, 2015. Tampa, Florida. Dev Abraham MD, MRCP (UK), ECNU Professor of Medicine, Division of Endocrinology, Huntsman Cancer Institute, University
Innovative RT SBRT. The variables with REQ in superscript are required.
The variables with REQ in superscript are required. The variables with a are single-select variables; only one answer can be selected. The variables with a are multi-select variables; multiple answers
Incidence of Incidental Thyroid Nodules on Computed Tomography (CT) Scan of the Chest Performed for Reasons Other than Thyroid Disease
International Journal of Clinical Medicine, 2011, 2, 264-268 doi:10.4236/ijcm.2011.23042 Published Online July 2011 (http://www.scirp.org/journal/ijcm) Incidence of Incidental Thyroid Nodules on Computed
General Rules SEER Summary Stage 2000. Objectives. What is Staging? 5/8/2014
General Rules SEER Summary Stage 2000 Linda Mulvihill Public Health Advisor NCRA Annual Meeting May 2014 National Center for Chronic Disease Prevention and Health Promotion Division of Cancer Prevention
Male. Female. Death rates from lung cancer in USA
Male Female Death rates from lung cancer in USA Smoking represents an interesting combination of an entrenched industry and a clearly drug-induced cancer Tobacco Use in the US, 1900-2000 5000 100 Per Capita
Breast cancer close to the nipple: Does this carry a higher risk ofaxillary node metastasesupon diagnosis?
Breast cancer close to the nipple: Does this carry a higher risk ofaxillary node metastasesupon diagnosis? Erin I. Lewis, BUSM 2010 Cheri Nguyen, BUSM 2008 Priscilla Slanetz, M.D., MPH Al Ozonoff, Ph.d.
Radiographic Findings and Comments
642 Abdomen (Cont.) Differential Diagnosis of Abdominal s E. Focal parenchymal calcification of the kidney Tuberculosis (Fig. 27.19) Adenocarcinoma (Fig. 27.20) Nephroblastoma (Wilms tumor) (Fig. 27.21)
Thyroid Cancer Diagnosis and Management. Jerome Hershman, M.D. Internal Medicine Grand Rounds University of Missouri, Columbia October 21, 2010
Thyroid Cancer Diagnosis and Management Jerome Hershman, M.D. Internal Medicine Grand Rounds University of Missouri, Columbia October 21, 2010 DISCLOSURE NOTHING TO DISCLOSE in regard to financial conflict
Cancer: DNA Synthesis, Mitosis, and Meiosis
Chapter 5 Cancer: DNA Synthesis, Mitosis, and Meiosis Copyright 2007 Pearson Copyright Prentice Hall, 2007 Inc. Pearson Prentice Hall, Inc. 1 What Is Cancer? Benign tumors do not invade surrounding tissue
UNDERSTANDING SERIES LUNG NODULES. 1-800-298-2436 LungCancerAlliance.org
UNDERSTANDING SERIES LUNG NODULES 1-800-298-2436 LungCancerAlliance.org CONTENTS What is a Nodule?...2 Finding Nodules...3 If a Nodule is Found... 4 What Happens Next?...6 Questions to Ask about Your Results...7
Diabetes Research Investigator Profiles
Diabetes Research Investigator Profiles Dr. Edith Arany, MD, Ph.D., Dr. Arany is an imaging scientist at Lawson and an assistant professor in the departments of Medical Biophysics, Pathology and Medicine
Targeted Therapy What the Surgeon Needs to Know
Targeted Therapy What the Surgeon Needs to Know AATS Focus in Thoracic Surgery 2014 David R. Jones, M.D. Professor & Chief, Thoracic Surgery Memorial Sloan Kettering Cancer Center I have no disclosures
Transperitoneal laparoscopic adrenalectomy for metachronous contralateral
Transperitoneal laparoscopic adrenalectomy for metachronous contralateral adrenal metastasis from renal cell carcinoma: a case report Evangelos Zacharakis* 1, Maria Jose Ribal 1, Emmanouil Zacharakis 2
Small Cell Lung Cancer
Small Cell Lung Cancer Types of Lung Cancer Non-small cell carcinoma (NSCC) (87%) Adenocarcinoma (38%) Squamous cell (20%) Large cell (5%) Small cell carcinoma (13%) Small cell lung cancer is virtually
OBJECTIVES By the end of this segment, the community participant will be able to:
Cancer 101: Cancer Diagnosis and Staging Linda U. Krebs, RN, PhD, AOCN, FAAN OCEAN Native Navigators and the Cancer Continuum (NNACC) (NCMHD R24MD002811) Cancer 101: Diagnosis & Staging (Watanabe-Galloway
A Practical Guide to Advances in Staging and Treatment of NSCLC
A Practical Guide to Advances in Staging and Treatment of NSCLC Robert J. Korst, M.D. Director, Thoracic Surgery Medical Director, The Blumenthal Cancer Center The Valley Hospital Objectives Revised staging
THE PRACTICE of abdominal surgery was dramatically
0021-972X/98/$03.00/0 Vol. 83, No. 9 Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright 1998 by The Endocrine Society THERAPEUTIC CONTROVERSY The Role of Laparoscopic Surgery
SEMESTER VI 3 RD YEAR PATHOLOGY KIDNEY TUMORS
SEMESTER VI 3 RD YEAR PATHOLOGY KIDNEY TUMORS LEARNING OBJECTIVES At the end of the lecture, students should be able to: Know the pathology of renal tumors. RENAL TUMORS RENAL PAPILLARY ADENOMA Common
Corporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: microwave_tumor_ablation 12/2011 11/2015 11/2016 11/2015 Description of Procedure or Service Microwave ablation
- Slide Seminar - Endocrine pathology in non-endocrine organs. Case 11. Stefano La Rosa, Gioacchino D Ambrosio, Fausto Sessa
- Slide Seminar - Endocrine pathology in non-endocrine organs Case 11 Stefano La Rosa, Gioacchino D Ambrosio, Fausto Sessa Dept. of Pathology, Multimedica, Milan, Italy Dept. of Surgical and Morphological
An Interprofessional Approach to Diabetes Management
Disclosures An Interprofessional Approach to Diabetes Management Principal in DiabetesReframed, LLC. Inventor of U.S. Provisional Patent Application No. 61/585,483 METHODS OF USING A DIABETES CROSS- DISCIPLINARY
LUNG CANCER SCREENING: UNDERSTANDING LUNG NODULES. 1-800-298-2436 LungCancerAlliance.org
LUNG CANCER SCREENING: UNDERSTANDING LUNG NODULES 1-800-298-2436 LungCancerAlliance.org 1 1 CONTENTS What is a Nodule?...3 Finding Nodules...4 If a Nodule Is Found...5 What Happens Next?...7 Questions
Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? www.simpsonmillar.co.uk Telephone 0844 858 3200
GUIDE TO ASBESTOS LUNG CANCER What Is Asbestos Lung Cancer? Like tobacco smoking, exposure to asbestos can result in the development of lung cancer. Similarly, the risk of developing asbestos induced lung
Il percorso diagnostico del nodulo tiroideo: il ruolo dell analisi molecolare
Il percorso diagnostico del nodulo tiroideo: il ruolo dell analisi molecolare Maria Chiara Zatelli Sezione di Endocrinologia Direttore: Prof. Ettore degli Uberti Dipartimento di Scienze Mediche Università
VI. FREQUENTLY ASKED QUESTIONS CONCERNING BREAST IMAGING AUDITS
ACR BI-RADS ATLAS VI. FREQUENTLY ASKED QUESTIONS CONCERNING BREAST IMAGING AUDITS American College of Radiology 55 ACR BI-RADS ATLAS A. All Breast Imaging Modalities 1. According to the BI-RADS Atlas,
Radiotherapy in locally advanced & metastatic NSC lung cancer
Radiotherapy in locally advanced & metastatic NSC lung cancer Dr Raj Hegde. MD. FRANZCR Consultant Radiation Oncologist. William Buckland Radiotherapy Centre. Latrobe Regional Hospital. Locally advanced